The DTRAX® platform includes innovative instruments and implants used in spine surgery. The current product line is designed primarily to achieve indirect decompression and fusion of the cervical spine.
DTRAX Spinal System is a set of single-use disposable instruments designed for use with a range of spinal implants. The system enables access to the spine through posterior surgical incisions, and preparation of the bony elements and joints. Spinal fusion with DTRAX Spinal System does not require removal of bone, soft tissue, or stabilizing ligaments.
The DTRAX Cervical Cage is used to treat cervical radiculopathy caused by degenerative disc disease by indirectly decompressing and fusing the diseased spinal joint.
The DTRAX Graft is a structural allograft implanted in the cervical facets to support posterior fusion. When implanted, DTRAX Graft provides an indirect decompression of the nerve roots by distracting the facets and opening the neuroforamen.
The DTRAX Bone Screws are indicated for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, fracture repair, and fracture fixation appropriate for the size of the device. Screws are intended for single use only and are implanted using DTRAX Spinal System.
DTRAX Bone Screw may be used as supplemental fixation along with DTRAX Cervical Cage for joint fusion.
DTRAX Facet System is a sterile, single-use kit containing all the tools and implants that are needed to perform a single level surgery. The system includes a proprietary, expandable, titanium implant that is used to provide indirect decompression and fusion of cervical facets.
DTRAX technology offers a less disruptive alternative for patients suffering from cervical radiculopathy.
Unlike more invasive anterior surgical approaches, DTRAX technology enables innovative posterior (from the patient’s back) approach that typically requires two small incisions at the base of the patient's neck.
Patients who suffer from neck and/or arm pain due to degenerative disc disease may be treatable with spinal stabilization with DTRAX technology. Proper diagnosis of cervical radiculopathy followed by at least six weeks of conservative care is recommended before considering any surgery.
Cervical radiculopathy is characterized by:
With the DTRAX technology, first your surgeon relieves pressure on your spinal nerves by distracting (opening) the joints so the nerves are no longer irritated. Then two implants and graft material are inserted to enable healing of these joints.
Alternative Surgical Options
Anterior Cervical Decompression and Fusion (ACDF) - One of the most common surgeries used to treat cervical radiculopathy, ACDF removes tissue from the body and involves bone grafting and plates through the front of the neck.
Open Posterior Cervical Decompression and Fusion - The posterior approach to the cervical spine requires dissection of muscle and tissue off the spine, plus insertion of plates and screws. These surgeries typically are very painful and the injured muscles.
Artificial Disc Replacement - Indicated for a small-set of patients with early on-set disc degeneration.
Clinical trials studying posterior spinal stabilization with DTRAX technology demonstrate that the procedure is effective at reliving neck and arm pain associated with cervical radiculopathy.1
1. Percutaneous posterior cervical fusion with the DTRAX Facet System for single-level radiculopathy: results in 60 patients. Bruce M. McCormack, Jose Manuel F. Ignacio, Rafael C. Bundoc, Sigurd H. Berven, Mario R. Ver, and Edward F. Eyster. 10.3171/2012/12.SPINE12477.
Spinal stabilization with DTRAX is typically performed by a specially trained surgeon and usually takes about one hour. Published clinical data demonstrates that most patients experience rapid and lasting improvement in symptoms.Contact us to learn more about how DTRAX can improve your life.
A privately-held medical device company developing minimally invasive solutions addressing the $1 billion worldwide cervical spine market. Commercializing the DTRAX platform of minimally invasive posterior cervical implants and instruments to treat cervical degenerative disc disease through indirect decompression and stabilization.
David Cash (Principal, Stanmore Medical Investments)
Bruce McCormack, M.D. (Neuro Surgeon, NeuroSpine Institute Medical Group)
Ned Scheetz (Managing Director, Aphelion Capital)
Jeff Smith (CEO, Providence Medical Technology)
Art Taylor (COO and CFO, Topera Inc.)
Jeff Smith (CEO, Co-Founder, Director)
Bruce McCormack, M.D. (President, Co-Founder, Director)
David Schummers (VP, Marketing)
Kevin Shaw (VP, Sales)
Edward Liou (VP, Engineering and Operations)
Congress of Neurological Surgeons (CNS)
October 18-22, 2014 — Boston, MA
North American Spine Society (NASS)
November 12-15, 2014 - San Francisco, CA
Providence Medical Technology, Inc.
3650 Mt. Diablo Ave, Suite 104
Lafayette, CA 94549
Tel: (415) 923-9376
Fax: (415) 923-9377